[This is the first systematic preclinical study to show that TIMP3 may be a potential molecular tool for colon cancer biological therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE